What kind of message does it send when they actually get elevated?

It is the process. We have set up a system where nobody gets fired.

We have got a few rotten apples in the barrel, and they are still in the barrel, and to me it is disgraceful that we haven't fixed the system that allows you to do your duty to clear the deck of people who need to be fired, removed, and…

No one wishes for a friend, family member, or a loved one to succumb to addiction.

I look forward to today's hearing. We have a truly excellent panel of witnesses and I yield back the balance of my time.

Without objection, so ordered.

Unfortunately, for many, these concerns extend to the markets for other lifesaving treatments as well.

Clearly, this is anti-competitive conduct that should be swiftly and harshly punished.

Then in 35 seconds, Dr. Ketcham, your testimony lays out that there are many barriers experienced by first responders and medical professionals in an effort to respond to these overdoses.

I am personally concerned about the high cost of the new treatment for Hepatitis C, a virus that affects more than 4 million Americans and which costs nearly $75,000.

It is critical that our polices continue to place a high value on innovation.

If Congress wants to help increase access to these drugs, then something must be done to curtail the cost of these lifesaving medications.

I think sometimes government regulations are interfering with that.

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, billion-dollar rules are among the worst offenses of the pen-and-phone Obama administration. This administration is using overreaching billion-dollar rules to insert…

Mr. Chairman, I demand a recorded vote. The CHAIR. Pursuant to clause 6 of rule XVIII, further proceedings on the amendment offered by the gentlewoman from Washington will be postponed. Announcement by the Chair The CHAIR. Pursuant to…

Once again, the REVIEW Act applies to all new billion- dollar rules. The bill's relief is urgently needed. Failures to require stays of billion-dollar rules during litigation wastes billions of dollars in unnecessary compliance costs and…

Mr. Chairman, action on the REVIEW Act is a reasonable step on our part to continue proper and responsible regulatory reform. In the end, this is a bill that encourages smaller, sensible rulemaking. When the costs are borne on the back of…

Mr. Chairman, I thank the full committee chairman, Mr. Goodlatte, for supporting the REVIEW Act as an original cosponsor and for moving it through the Judiciary Committee. I am also grateful for the many other Members who have cosponsored…